Head-to-head · WeighScore
BodyLogicMD vs ShedRx
The verdict
ShedRx takes it — 87/100 to 63.4/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BodyLogicMD | ShedRx |
|---|---|---|
| WeighScore | 63.4/100 | 87/100 |
| Grade | C | B+ |
| Scorecard rank | #254 | #3 |
| Semaglutide | Not disclosed | $199/mo |
| Tirzepatide | Not disclosed | $299/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #254 · C
Strengths
- Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
- Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
- Transparent $79/month membership, no insurance required, cancel anytime
Where it loses points
- GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
- Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
- State availability and dispensing pharmacy are not disclosed on the marketing site
Graded #3 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
Where it loses points
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.